229 related articles for article (PubMed ID: 16792410)
1. Synthesis of salvinorin A analogues as opioid receptor probes.
Tidgewell K; Harding WW; Lozama A; Cobb H; Shah K; Kannan P; Dersch CM; Parrish D; Deschamps JR; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jun; 69(6):914-8. PubMed ID: 16792410
[TBL] [Abstract][Full Text] [Related]
2. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: semisynthesis of salvinicins A and B and other chemical transformations of salvinorin A.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Gilmour B; Navarro H; Rothman RB; Prisinzano TE
J Nat Prod; 2006 Jan; 69(1):107-12. PubMed ID: 16441078
[TBL] [Abstract][Full Text] [Related]
3. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: preparation and opioid receptor activity of salvinicin analogues.
Simpson DS; Katavic PL; Lozama A; Harding WW; Parrish D; Deschamps JR; Dersch CM; Partilla JS; Rothman RB; Navarro H; Prisinzano TE
J Med Chem; 2007 Jul; 50(15):3596-603. PubMed ID: 17580847
[TBL] [Abstract][Full Text] [Related]
4. Neoclerodane diterpenes as a novel scaffold for mu opioid receptor ligands.
Harding WW; Tidgewell K; Byrd N; Cobb H; Dersch CM; Butelman ER; Rothman RB; Prisinzano TE
J Med Chem; 2005 Jul; 48(15):4765-71. PubMed ID: 16033256
[TBL] [Abstract][Full Text] [Related]
5. Salvinicins A and B, new neoclerodane diterpenes from Salvia divinorum.
Harding WW; Tidgewell K; Schmidt M; Shah K; Dersch CM; Snyder J; Parrish D; Deschamps JR; Rothman RB; Prisinzano TE
Org Lett; 2005 Jul; 7(14):3017-20. PubMed ID: 15987194
[TBL] [Abstract][Full Text] [Related]
6. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: exploration of the 1-position.
Holden KG; Tidgewell K; Marquam A; Rothman RB; Navarro H; Prisinzano TE
Bioorg Med Chem Lett; 2007 Nov; 17(22):6111-5. PubMed ID: 17904842
[TBL] [Abstract][Full Text] [Related]
7. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: selective modification of the furan ring.
Harding WW; Schmidt M; Tidgewell K; Kannan P; Holden KG; Dersch CM; Rothman RB; Prisinzano TE
Bioorg Med Chem Lett; 2006 Jun; 16(12):3170-4. PubMed ID: 16621556
[TBL] [Abstract][Full Text] [Related]
8. Synthesis and in vitro pharmacological studies of new C(2) modified salvinorin A analogues.
Lee DY; Karnati VV; He M; Liu-Chen LY; Kondaveti L; Ma Z; Wang Y; Chen Y; Beguin C; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2005 Aug; 15(16):3744-7. PubMed ID: 15993589
[TBL] [Abstract][Full Text] [Related]
9. Opioid receptors and legal highs: Salvia divinorum and Kratom.
Babu KM; McCurdy CR; Boyer EW
Clin Toxicol (Phila); 2008 Feb; 46(2):146-52. PubMed ID: 18259963
[TBL] [Abstract][Full Text] [Related]
10. Salvinorin A, an active component of the hallucinogenic sage salvia divinorum is a highly efficacious kappa-opioid receptor agonist: structural and functional considerations.
Chavkin C; Sud S; Jin W; Stewart J; Zjawiony JK; Siebert DJ; Toth BA; Hufeisen SJ; Roth BL
J Pharmacol Exp Ther; 2004 Mar; 308(3):1197-203. PubMed ID: 14718611
[TBL] [Abstract][Full Text] [Related]
11. Synthetic studies of neoclerodane diterpenes from Salvia divinorum: role of the furan in affinity for opioid receptors.
Simpson DS; Lovell KM; Lozama A; Han N; Day VW; Dersch CM; Rothman RB; Prisinzano TE
Org Biomol Chem; 2009 Sep; 7(18):3748-56. PubMed ID: 19707679
[TBL] [Abstract][Full Text] [Related]
12. Salvinorin A: from natural product to human therapeutics.
Vortherms TA; Roth BL
Mol Interv; 2006 Oct; 6(5):257-65. PubMed ID: 17035666
[TBL] [Abstract][Full Text] [Related]
13. New neoclerodane diterpenoids isolated from the leaves of Salvia divinorum and their binding affinities for human kappa opioid receptors.
Lee DY; Ma Z; Liu-Chen LY; Wang Y; Chen Y; Carlezon WA; Cohen B
Bioorg Med Chem; 2005 Oct; 13(19):5635-9. PubMed ID: 16084728
[TBL] [Abstract][Full Text] [Related]
14. Divinatorins A-C, new neoclerodane diterpenoids from the controlled sage Salvia divinorum.
Bigham AK; Munro TA; Rizzacasa MA; Robins-Browne RM
J Nat Prod; 2003 Sep; 66(9):1242-4. PubMed ID: 14510607
[TBL] [Abstract][Full Text] [Related]
15. Semisynthetic neoclerodanes as kappa opioid receptor probes.
Lovell KM; Vasiljevik T; Araya JJ; Lozama A; Prevatt-Smith KM; Day VW; Dersch CM; Rothman RB; Butelman ER; Kreek MJ; Prisinzano TE
Bioorg Med Chem; 2012 May; 20(9):3100-10. PubMed ID: 22464684
[TBL] [Abstract][Full Text] [Related]
16. Total synthesis of the hallucinogenic neoclerodane diterpenoid salvinorin A.
Nozawa M; Suka Y; Hoshi T; Suzuki T; Hagiwara H
Org Lett; 2008 Apr; 10(7):1365-8. PubMed ID: 18311991
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and in vitro pharmacological studies of new C(4)-modified salvinorin A analogues.
Lee DY; He M; Liu-Chen LY; Wang Y; Li JG; Xu W; Ma Z; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2006 Nov; 16(21):5498-502. PubMed ID: 16945525
[TBL] [Abstract][Full Text] [Related]
18. Synthesis and in vitro pharmacological studies of C(4) modified salvinorin A analogues.
Lee DY; He M; Kondaveti L; Liu-Chen LY; Ma Z; Wang Y; Chen Y; Li JG; Beguin C; Carlezon WA; Cohen B
Bioorg Med Chem Lett; 2005 Oct; 15(19):4169-73. PubMed ID: 16051487
[TBL] [Abstract][Full Text] [Related]
19. Synthesis and κ-opioid receptor activity of furan-substituted salvinorin A analogues.
Riley AP; Groer CE; Young D; Ewald AW; Kivell BM; Prisinzano TE
J Med Chem; 2014 Dec; 57(24):10464-75. PubMed ID: 25426797
[TBL] [Abstract][Full Text] [Related]
20. Studies toward the pharmacophore of salvinorin A, a potent kappa opioid receptor agonist.
Munro TA; Rizzacasa MA; Roth BL; Toth BA; Yan F
J Med Chem; 2005 Jan; 48(2):345-8. PubMed ID: 15658846
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
